Accountability
A clear owner for every publication decision.
PeptidePharmacies records who owns the website content, which checks have been completed and which product facts remain unverified.
Website operator approval recorded 3 September 2026. This is not a professional, regulatory or product-classification approval.
Publication owner
PeptidePharmacies site operator
The operator is accountable for the public catalogue, enquiry routes and website guidance.
No individual professional credential, regulatory appointment or named technical reviewer is claimed on this page. Named people and qualifications will be added only after identity and evidence have been verified.
Questions about a page, sourcing reference or enquiry record can be sent to contact@peptidepharmacies.com.
Control record
What the operator owns
Publication approval and product approval are kept separate so a visible catalogue name cannot be mistaken for evidence of stock, specification or lawful supply.
- Publication control
- Approve, correct or withdraw website pages and record the date of the decision.
- Enquiry handling
- Route submitted business, professional and institutional requirements for human review and retain their reference.
- Evidence boundaries
- Keep unknown product, licence, market and capability details explicitly unconfirmed.
- Document matching
- Require batch- or supplier-specific records to be confirmed against the material and requirement concerned.
- Escalation
- Hold or refuse publication and supply claims when classification, buyer or destination requirements are unresolved.
Reviewed supply modelOwner publication approval permits the sourcing index and procurement guidance to be public. It does not certify any molecule, supplier, batch, intended use, buyer or destination.
See the review framework
The compliance page explains how unclassified references remain separate from Tier 1–2 approved product records.